Neutrisci International Stock Current Valuation
NU Stock | CAD 12.53 1.00 7.39% |
Valuation analysis of NeutriSci International helps investors to measure NeutriSci International's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -3.61 in 2024. Enterprise Value Multiple is likely to drop to -3.61 in 2024. Fundamental drivers impacting NeutriSci International's valuation include:
Price Book 20.2848 | Enterprise Value 1.1 M | Enterprise Value Ebitda (3.85) | Price Sales 29.7453 | Enterprise Value Revenue 33.2406 |
Undervalued
Today
Please note that NeutriSci International's price fluctuation is not too volatile at this time. Calculation of the real value of NeutriSci International is based on 3 months time horizon. Increasing NeutriSci International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NeutriSci stock is determined by what a typical buyer is willing to pay for full or partial control of NeutriSci International. Since NeutriSci International is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NeutriSci Stock. However, NeutriSci International's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 12.53 | Real 13.37 | Hype 12.53 | Naive 13.07 |
The intrinsic value of NeutriSci International's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NeutriSci International's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NeutriSci International helps investors to forecast how NeutriSci stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NeutriSci International more accurately as focusing exclusively on NeutriSci International's fundamentals will not take into account other important factors: NeutriSci International Company Current Valuation Analysis
NeutriSci International's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current NeutriSci International Current Valuation | 1.1 M |
Most of NeutriSci International's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeutriSci International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
NeutriSci Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for NeutriSci International is extremely important. It helps to project a fair market value of NeutriSci Stock properly, considering its historical fundamentals such as Current Valuation. Since NeutriSci International's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of NeutriSci International's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of NeutriSci International's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, NeutriSci International has a Current Valuation of 1.1 M. This is 99.99% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all Canada stocks is 99.99% higher than that of the company.
NeutriSci International is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 2.2 Million. NeutriSci International totals roughly 1.1 Million in current valuation claiming about 50% of equities under Health Care industry.NeutriSci International Current Valuation Drivers
We derive many important indicators used in calculating different scores of NeutriSci International from analyzing NeutriSci International's financial statements. These drivers represent accounts that assess NeutriSci International's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of NeutriSci International's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 2.9M | 18.6M | 8.7M | 2.5M | 2.2M | 2.1M | |
Enterprise Value | 2.9M | 18.6M | 8.8M | 2.5M | 2.2M | 2.1M |
NeutriSci Fundamentals
Return On Equity | -6.11 | ||||
Return On Asset | -1.76 | ||||
Operating Margin | (34.30) % | ||||
Current Valuation | 1.1 M | ||||
Shares Outstanding | 178.42 M | ||||
Shares Owned By Insiders | 1.03 % | ||||
Number Of Shares Shorted | 4.87 K | ||||
Price To Earning | (2.57) X | ||||
Price To Book | 20.28 X | ||||
Price To Sales | 29.75 X | ||||
Revenue | 59.98 K | ||||
Gross Profit | (102.95 K) | ||||
EBITDA | (532.61 K) | ||||
Net Income | (552.45 K) | ||||
Cash And Equivalents | 152.47 K | ||||
Total Debt | 178.63 K | ||||
Debt To Equity | 0.31 % | ||||
Current Ratio | 1.10 X | ||||
Book Value Per Share | (0.01) X | ||||
Cash Flow From Operations | (264.69 K) | ||||
Short Ratio | 0.44 X | ||||
Beta | 0.82 | ||||
Market Capitalization | 892.12 K | ||||
Total Asset | 331.43 K | ||||
Retained Earnings | (36.47 M) | ||||
Working Capital | (689.31 K) | ||||
Net Asset | 331.43 K |
About NeutriSci International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeutriSci International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeutriSci International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeutriSci International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NeutriSci Stock Analysis
When running NeutriSci International's price analysis, check to measure NeutriSci International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeutriSci International is operating at the current time. Most of NeutriSci International's value examination focuses on studying past and present price action to predict the probability of NeutriSci International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeutriSci International's price. Additionally, you may evaluate how the addition of NeutriSci International to your portfolios can decrease your overall portfolio volatility.